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ABSTRACT Molecular dynamics simulations have been
performed (AMBER version 3.1) on solvated residues 1-65 of
bovine prothrombin fragment 1 (BF1) by using the 2.8-A
resolution crystallographic coordinates as the starting confor-
mation for understanding calcium ion-induced conformational
changes that precede experimentally observable phospholipid
binding. Simulations were performed on the non-metal-bound
crystal structure, the form resulting from addition of eight
calcium ions to the 1-65 region of the crystal structure, the
form resulting from removal of calcium ions after 107 ps and
continuing the simulation, and an isolated hexapeptide loop
(residues 18-23). In all cases, the 100-ps time scale seemed
adequate to sample an ensemble of solution conformers within
a particular region of conformation space. The non-metal-
containing BF1 did not unfold appreciably during a 106-ps
simulation starting from the crystallographic geometry. The
calcium ion-containing structure (Ca-BF1) underwent an in-
teresting conformational reorganization during its evolution
from the crystal structure: during the time course of a 107-ps
simulation, Ca-BF1 experienced a trans -* cis isomerization of
the y-carboxyglutamic acid-21 (Gla-21)-Pro-22 peptide bond.
Removal of the calcium ions from this structure followed by 114
ps of additional molecular dynamics showed significant un-
folding relative to the final 20-ps average structure ofthe 107-ps
simulation; however, the Gla-21-Pro-22 peptide bond re-
mained cis. A 265-ps simulation on the termini-protected
hexapeptide loop (Cys-18 to Cys-23) containing two calcium
ions also did not undergo a trans -* cis isomerization. It is
believed that the necessary activation energy for the transi-
tional event observed in the Ca-BF1 simulation was largely
supplied by global conformational events with a possible assist
from relief of intermolecular crystal packing forces. The pres-
ence of a Gla preceding Pro-22, the inclusion of Pro-22 in a
highly strained loop structure, and the formation of two
long-lived salt bridges prior to isomerization may all contribute
to this finding.
Prothrombin, a protein of central importance in the coagu-
lation cascade, is converted to thrombin by the action of a
macromolecular complex involving the protease factor Xa
bound to the membrane protein factor Va. The conversion
occurs on the surface of the membrane; binding of the
substrate, prothrombin, is mediated by calcium ions. Mag-
nesium ions do not support the prothrombin-membrane
interaction (1-6). Bovine fragment 1 (BF1) corresponds to
the amino-terminal 156 residues of bovine prothrombin; the
first 33 amino acids contain 10 y-carboxyglutamic acid (Gla)
residues. These Gla residues are created by means of post-
translational modification of glutamic acid residues in the
presence of a vitamin K-dependent carboxylase and endow
prothrombin with its essential calcium-mediated phospholip-
id-binding properties (1). The Gla domain ofprothrombin has
classically referred to the first 48 residues of the amino-
terminal region and is highly conserved in other protein
members of the coagulation cascade: factors VII, IX, and X
of the procoagulant cascade and proteins C, S, and Z of the
anticoagulant loop. Even though they are highly homologous
(65-70%) in the Gla domain, these proteins display different
metal-binding properties, as the number of Gla residues
ranges from 9 to 12 (7). An important question presents itself
here as to whether the structural differences are relevant to
corresponding differences in function. With the aid of the
calcium-containing BF1 (Ca-BF1) crystal structure (7), we
can approximate the other Gla-containing proteins and per-
form simulations to determine differences in the presence and
absence of divalent ions.
Although there is a large body of experimental observa-
tions pertaining to Ca-BF1, there was little structural infor-
mation known (8-12) until the recent crystallographic deter-
mination. In the absence of calcium ions, the first 35 residues
of the Gla domain are disordered in the apo structure (9, 10).
Thus, calcium-mediated phospholipid binding might initially
depend on a calcium ion-induced folding transition of the
amino-terminal 35 residues (7). An interesting experimental
observation by Nelsestuen (1) showed a biphasic fluores-
cence quenching behavior for BF1 upon the addition of metal
ions. This quench of intrinsic tryptophan fluorescence par-
allels the phospholipid-binding behavior of BF1 and bovine
prothrombin. An initial rapid quench (<1 s) is followed by a
slow quenching phase (>10 min); the latter has been hypoth-
esized by Marsh et al. (13) to represent an isomerization of
the Gla-21-Pro-22 peptide bond from trans to cis. The initial
fluorescence quenching event may be the result of an inter-
action of the disulfide of the small conserved hexapeptide
loop (residues 18-23) with a three-dimensional cluster of
aromatic residues (Phe41, Trp42, and Tyr45), which is also
highly conserved (7). The proline isomerization hypothesis is
consistent with both experimental (14-21) and theoretical
(22) investigations, which indicate that proline isomerization
may be the rate-limiting step in protein folding pathways.
Since the isomeric structure of Pro-22 is not clear at the
present level of refinement of the crystallographic structure
(2.8-A resolution) and the same applies to the location of
calcium ion positions (7), we have used molecular dynamics
(MD) to generate potential solution conformations by allow-
ing relaxation of the crystallographic structure of Ca-BF1
under several conditions. Analysis of these simulations is
then performed in light of the previous observations.
Abbreviations: BF1, bovine fragment 1; MD, molecular dynamics;
rms, root-mean-square; Gla, y-carboxyglutamic acid; Ca-BF1, cal-
cium-containing BF1.
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COMPUTATIONAL METHODS
General. The first 65 residues [Ca-BF1-(1-65)] were chosen
as a model of BF1 because recent evidence shows this region
to functionally constitute the Gla domain (7, 23). An
N-methyl cap was graphically placed on Asn-65 for all Gla
domain calculations by using the MULTI software (24). All
calculations were performed using AMBER version 3.1 (25)
under the following conditions unless otherwise noted: hy-
drogens were added to the heavy atom crystallographic
coordinates followed by immersion in a periodic box con-
taining TIP3P waters. Gla parameters came from ref. 26. For
the metal-containing calculations, the non-bond parameters
employed were r, = 1.65 A, e = 0.1 kcal/mol for calcium; r,
= 1.10 A, e = 0.1 kcal/mol for magnesium (27). Structures
were initially minimized (100 cycles of steepest descent
followed by conjugate gradient minimization) to a root-mean-
square (rms) gradient of 0.1 kcal'mo-l'A- by employing an
8.0-A residue-based non-bond cutoff, constant dielectric
function, all-atom force field, and constant pressure with
periodic boundary conditions. MD simulations were then
performed employing velocity scaling to maintain a constant
temperature of 300 K. A 1.0-fs time step was used and the
SHAKE (25) algorithm was applied to constrain all bonds
involving hydrogens. A mass of 3 atomic mass units was used
for all hydrogens, and the non-bond list was updated every 50
steps.
All calculations were performed on a Cray-YMP/8-432
supercomputer at the North Carolina Supercomputer Center.
Molecular dynamics trajectories were analyzed statistically
(24, 25) as well as graphically by means ofa movie (24) of the
simulation on a Silicon Graphics IRIS 240 GTX workstation.
Simulation of Ca-BF1-(1-65). Although the crystal struc-
ture was solved in the presence of calcium ions, the actual
calcium ion positions are not known at 2.8-A resolution.
Potential calcium positions were estimated by energy mini-
mization of the crystal structure using a distance-dependent
dielectric function and an 8.0-A non-bond cutoff. One hun-
dred cycles of steepest descent minimization were initially
performed followed by 2100 cycles of conjugate gradient
minimization. rms comparisons using the COMPARE program
(28) were then performed on all Gla oxygen positions. It was
rationalized that any previously metal-bound ligands (i.e.,
oxygen atoms) would have moved significantly from the
crystallographic positions. Analysis of oxygen positions with
an rms deviation of >2.0 A from the crystal structure showed
8 of the 10 Gla residues to be likely calcium site candidates.
This prediction is in reasonable agreement with Scatchard
analysis based on equilibrium dialysis studies, which report
either six (5, 29) or seven (30) significant calcium binding sites
in BF1. One of these sites may lie outside of the 1-65
sequence examined in the present study (A.T., unpublished
data; ref. 31). Calcium ions were graphically placed in the
eight rms-predicted metal-binding sites of the original crys-
tallographic structure in an attempt to maximize potential
Gla-metal interactions while avoiding steric conflicts or
disruption of any stabilizing (e.g., salt bridge) interactions.
The system was then subjected to the general methods
described above, and molecular dynamics was performed for
107 ps.
Another simulation included removal of the metal ions
after 107 ps, resolvation of the non-metal-bound protein, and
reminimization in a water bath followed by 114 ps of MD, as
previously described for the calcium structure.
Simulation of Non-Metal-Containing BF1 (Residues 1-65).
The original crystal coordinates (N-methyl-capped residues
1-65) were minimized initially in vacuo, then solvated in a
water bath, reminimized, and subjected to 106 ps of MD
simulation according to the methodology described above.
Simulation of the Isolated Hexapeptide Loop (Residues 18-
23). Residues 18-23 were removed from the original crystal
structure, and the amino terminus (Cys-18) was capped with
an acetyl group while the carboxyl terminal (Cys-23) was
protected with an N-methyl group. Two calcium ions were
graphically placed between Gla residues 20 and 21, and this
system was minimized in a water bath and subjected to 265
ps of MD according to the usual procedure.
RESULTS AND DISCUSSION
The prediction of potential macromolecule solution confor-
mations can be facilitated by the use ofMD simulations. Ifthe
starting geometry is derived from a crystal structure, it is not
surprising that time evolution in a thermal water bath may, in
some cases, allow for significant structural changes from the
initial conformation influenced by crystal packing forces.
Differences between crystal structures and solution struc-
tures of proteins as determined by two-dimensional NMR are
known (32). Although MD can be used to generate potential
solution structures, a difficulty is that it is not always clear
how long a given MD simulation should be performed with
respect to the time scale ofobservable conformational events
to conclude a reasonable solution structure has been attained.
Simulation of Ca-BF1-(1-65). We performed 107 ps ofMD
on Ca-BF1-(1-65); an analysis of the extent of atomic dis-
placement of backbone (Cac-C-N) atoms from the crystal-
lographic geometry with respect to time for this simulation is
presented in Fig. 1. It appears that after some substantial
reorganization of structure (over the first 45 ps), the overall
rms deviation of backbone atoms for the remainder of the
trajectory is <1 A. This is indicative of an equilibrated
solution structure within the region of conformational space
that was explored by this calculation. Having found an
adequate sampling time, evaluation of overall motion on a
residue basis was performed. An average structure was
calculated for the final 20 ps of the simulation and compared
to the crystal structure in terms of a-carbon rms deviations
(Fig. 2). The region of Ca-BF1-(1-65) experiencing the great-
est amount of motion over the course of the simulation was
in the amino-terminal end of the protein from Ala-1 to Phe-5.
In the crystal structure, Ala-1 appears to be hydrogen bonded
to the backbone carbonyls of Leu-19 and Gla-20; in solution,
however, the amino hydrogens of Ala-1 are probably ex-
changing with solvent, thereby no longer restricting the





FIG. 1. rms deviation (rmsd) of backbone atoms of Ca-BF1-(1-
65) from crystal structure versus simulation time.
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FIG. 2. rms deviation (rmsd) of a-carbons of Ca-BF1-(1-65) for
the final 20-ps average structure (total time of simulation = 107 ps)
versus crystal structure. The comparison was residue based.
ronment around Arg-10 is also seen in Fig. 2. In the crystal
structure, Arg-10 does not interact with other Gla domain
residues; however, upon MD, strong hydrogen bonds form
with the backbone carbonyl oxygen of Val-9 and one of the
carboxylate oxygens of Gla-7, which then seem to persist
through the course of the simulation. The other regions of
significant deviation include portions of the two disulfide
loops of the Gla domain residues (18-23 and 48-61). These
loops appear to be stacked in the crystal structure and were
modeled to initially interact by means of a single calcium ion
bridging residues 20 and 52-54.
Calcium Coordination. Evaluation ofthe eight calcium sites
for an indication ofcooperative motion over the course of the
simulation was also considered. It has been proposed that
there are from one to three tight-binding calcium sites in
Ca-BF1, but only one of these sites may be necessary for
inducing the conformational changes required of phospho-
lipid binding (30). It was, therefore, of interest to analyze the
coordination environment of each calcium before (0 ps) and
after (107 ps) the simulation to determine if such tight sites
could be identified. Reasonable criteria for a tight-binding
calcium site might be (i) involvement of more than one Gla
residue and (it) at least three short O-Ca2+ distances (rc, O '
2.6 A). With these criteria, we find, at 0 ps, two sites with
three Gla O-Ca2+ coordinations {[Gla-7, Gla-26 (2)] and
[Gla-17, Gla-27 (2)]}. At 107 ps we find five sites: one of these
sites contains four Gla O-Ca2+ coordinations {[Gla-7 (2),
Gla-26 (2)], two [Gla-20 (2), Gla-21], [Gla-17, Gla 27 (2)], and
[Gla 15 (2), Gla 30]}. The Gla-7, Gla-26 site is especially of
interest; if Gla-7, -8, and -33 are modified to -methylene-
glutamyl residues by means of a Tb3+/formaldehyde-
morpholine procedure (33), the modified protein loses most
of the ability to bind phospholipid, and Ca2` binding is
weaker and no longer cooperative. Further analysis shows
that, at the beginning of MD, there is a calcium ion bridging
Gla-20 of the hexapeptide disulfide loop (Cys-18 to Cys-23)
and the backbone carboxyl oxygens of Arg-52, Asn-53, and
Pro-54 of the tetradecapeptide loop (Cys-48 to Cys-61).
Graphical display ofthe simulation shows that Gla-20 "pulls"
this calcium away from the tetradecapeptide loop and then
begins to share this calcium with Gla-21 along with a second
calcium ion, which was weakly bound to Gla-20 at 0 ps. By
the end of the simulation, Gla residues 20 and 21 are involved
in a stable two-Gla, two-Ca2' ion site, which has persisted for
over 50 ps.
Isomerization of the Gla-21-Pro-22 Peptide Bond. A sig-
nificant result to arise from this work was the transitional
conformation change surrounding the Gla-21-Pro-22 pep-
tide bond. The crystal structure of Ca-BF1, which cannot
presently distinguish between cis and trans isomer, has this
peptide to be in the trans conformation; however, during the
107-ps MD simulation, this bond isomerized to the cis con-
former while all other peptide bonds in the structure re-
mained trans. This transition is illustrated in Fig. 3 by
monitoring the absolute torsional deviation of the Gla-
21-Pro-22 peptide from 1800 as a function of time. It is
apparent that, for the first 83 ps of the simulation, the trans
isomer is favored, but, at this transition time, the barrier to
isomerization is overcome. Although the AGI for trans -) cis
isomerism for most linear peptides is 20 ± 1 kcal/mol (34),
AG* for proline isomerization in small cyclic peptides is more
on the order of 15 ± 1 kcal/mol as determined by 13C and 1H
NMR in aqueous solution (35). An analysis of the potential
energies ofthe metal-bound protein at the MD conformations
over the isomerization period (82-85 ps) is given in Fig. 3
Inset to illustrate the barrier present in this system. A
five-point average ofthe data predicts an energy barrier of=9
kcal/mol; the cis structure is more stable by about 17
kcal/mol. It has been proposed that in cyclic peptides the
rates of proline isomerization are 6-fold higher (19) than
corresponding linear peptides. It has also been shown that the
steric contribution of the residue preceding proline has an
effect on the activation barrier for isomerization (18, 36). The
presence of Gla-21 preceding Pro-22 might contribute to a
lowering of the activation barrier since it is not a commonly
encountered residue. It is unlikely, however, that cis -* trans
isomerizations are localized events: the transitions between
energy minima probably involve concerted motion of many
different portions of the molecule. In fact, when the isolated
hexapeptide (Cys-18 to Cys-23) with two calcium ions (be-
tween Gla residues 20 and 21) was subjected to 265 ps ofMD
(identical conditions to the full 1-65 region simulation),
proline isomerization did not occur. Further evidence for a
concerted isomerization mechanism is evident from the dy-
namics ofinternal salt bridge formation during the simulation.
At the beginning of the simulation (0 ps), Arg-16 is salt
bridged to Asp-39; immediately prior to the transition, at 75
ps, while the Gla-21-Pro-22 peptide is still trans, two
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FIG. 3. Deviation (absolute) of torsional angle, w, for Gla-
21-Pro-22 as a function of simulation time. (Inset) MD single-point
potential energies expressed as a five point average versus simulation
time. Only the protein atoms were used to calculate the potential
energy; the potential energy was evaluated every 0.25 ps.
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FIG. 4. rms deviation of backbone atoms of non-metal-bound
BF1-(1-65) from crystal structure versus simulation time.
and Glu-49 and between Gla-20 and Arg-55. The isomeriza-
tion then occurs, and the integrity of these salt bridges is
maintained for the remainder of the simulation. One possible
rationalization for the proline isomerization is that (i) refold-
ing, combined with (ii) the potential lowering ofthe activation
barrier by Pro-22 being contained within a loop structure or
(iii) the presence of an adjacent Gla, as well as (iv) the
stabilizing salt bridges and the "jump" of the calcium ion
from the tetradecapeptide loop to Gla-20, all appear to
contribute to the isomerization to produce a more stable
solution conformation. An analysis ofintermolecular packing
between symmetry-related molecules (24) in the crystal
structure of Ca-BF1 shows significant interactions between
Gla domains that could be related to the large -degree of
structural reorganization that has occurred during the simu-
lation. Distances ranging from 3 to 5 A between side-chain
oxygens of Gla-7 of one molecule of Ca-BF1-(1-65) and
Glu-63 of an adjacent molecule could be due to calcium
bridging in the crystal structure. A pair of salt bridges
between Gla-8 and Arg-55 and between Arg-10 and Gla-33 of
neighboring structures also appears to be significant while
Gla-21 and Asn-13 of adjacent molecules share a hydrogen
bond.
Removal of Calcium Ions from the 107-ps MD Structure.
The eight calcium ions were removed from the 107-ps MD
Ca-BF1-(1-65) structure with cis proline at position 22. Upon
resolvation and further MD for 114 ps, considerable reorga-
nization occurred. The rms deviation of all backbone atoms
relative to the backbone 'atom positions of the average
structure for the final 20 ps of the initial simulation (i.e.,
87-107 ps) was compared to the 114-ps simulation. It is
noteworthy that the overall deviation is quite large (>3.0 A),
indicating that the calcium ions were intimately involved in
the maintenance of tertiary structure. It is also of note that
Pro-22 remains in the cis conformation, although other re-
gions of the protein appear to be changing dramatically.
Bajorath et al. (37) recently observed some significant crys-
tallographic structural changes in the subtilisin-type enzyme
proteinase K upon the removal of calcium ions, which
translated to a decrease in enzymatic activity.
Molecular Dynamics of the BF1 Crystal Structure Without
Calcium. In a control simulation, BF1-(1-65) was subjected
to 106 ps ofMD with no calcium ions present. In contrast to
the Ca-BF1 simulation, no trans -+ cis isomerization of
Pro-22 was observed.-A comparison of backbone atom rms
deviation for the 106-ps simulation with the crystal structure
is shown in Fig. 4. The 100-ps time scale seemed adequate for
sampling conformation space based upon the final 30 ps ofthe
simulation (Fig. 4). Although the equilibrated portions ofboth
the metal-bound and non-metal-bound simulations (Figs. 1
and 4, respectively) appear to be similar in overall magnitude
of deviation from the crystal structure, the portions of the
protein that have moved are quite different (the rms differ-
ence between backbone atoms in the average Ca-BF1 struc-
ture and the average non-metal BF1 structure is 4.7 A). A
least-squares fit between the a-helical portions (residues
35-47) of the crystal structure (Fig. 5A, thick lines) and
average (final 20 ps) Ca-BF1-(1-65) structure (Fig. SA, thin
lines) was performed since the a-helical portion ofthe protein
exhibits the least amount of overall motion in all simulations.
The same least-squares comparison was performed on the
crystal structure and the average (final 20 ps) structure of the
non-metal-bound simulation [Fig. SB: thick lines, crystal
structure; thin lines, average structure (86-106 ps)]. From
these comparisons, it becomes clear that the average calcium
structure has its 1-34 domain in a different orientation with
respect to the crystal structure than does the average non-
metal-bound structure even though the rms deviations for
both helical regions from the crystal structure are similar
FIG. 5. (A) View of least-squares fit of crystal structure (thick lines) and average Ca-BF1-(1-65) structure (final 20 ps, thin lines). (B) View
of least-squares fit of crystal structure (thick lines) and average non-metal-bound BF1-(1-65) structure (final 20 ps, thin lines). In both cases
the least-squares fit was performed on a-helical residues 35-47.
Biochemistry: Charifson et A
428 Biochemistry: Charifson et al.
(calcium structure, 1.5 A; non-calcium structure, 1.2 A). This
might be due to the fact that the Gla-containing region of the
calcium-bound structure can attain a solution conformation
that is inaccessible to the non-metal-bound structure. The
lack of unfolding during this simulation was unexpected,
especially since significant unfolding was observed when
calcium ions were removed from the 107-ps Ca-BF1 simula-
tion structure. When the Gla-21-Pro-22 peptide bond is
trans, the protein might be in one favorable energy minimum,
which remains stable even in the absence of calcium, but
which does not bind phospholipid. However, when isomer-
ization to the cis peptide occurs, new conformations are
attainable that require calcium for maintenance of tertiary
structure, which might be required of phospholipid binding.
CONCLUSIONS
The computational methodologies presented illustrate the
usefulness of MD in uncovering possible solution conforma-
tions starting with a crystal structure. The Ca-BF1 simula-
tion, for instance, provides us with a possible calcium-
induced phospholipid-binding conformation.
During the various simulations, several unexpected results
were obtained: the calcium ion-containing structure (Ca-
BF1) underwent a trans -+ cis isomerization about the
Gla-21-Pro-22 peptide bond, the only peptide bond to do so,
whereas the non-metal-containing BF1 structure did not, and
no significant unfolding occurred. Removal of the calcium
ions from the structure followed by additional MD showed
significant unfolding relative to the final 20-ps average cal-
cium structure; however, the Gla-21-Pro-22 peptide re-
mained cis. A lengthy simulation on the isolated hexapeptide
loop (Cys-18 to Cys-23) containing two calcium ions also did
not undergo a trans -- cis isomerization. The necessary
activation energy for the transitional event observed in the
Ca-BF1 simulation was probably largely dependent upon
global conformational events and by relief of intermolecular
crystal packing forces as evidenced by the lack of trans -* cis
isomerization in the isolated hexapeptide loop simulation.
Clearly, the chances of having observed a trans -- cis
isomerization on so short a time scale (100 ps), even with a
lowered activation energy (=9 kcal/mol), are unlikely with-
out other considerations. The presence of a Gla preceding
Pro-22, the inclusion of Pro-22 in a highly strained loop
structure, the jump of Ca2+ from the tetradecapeptide loop to
the hexapeptide loop, and the formation of two long-lived salt
bridges prior to isomerization may all contribute to the
isomerization. These may be the critical conformational
events that lead to the phospholipid-binding conformation in
the calcium-bound species and that is unattainable in the
non-metal-bound species. Ongoing simulations for which the
calcium ions have been replaced with magnesium ions (sim-
ulation length = 113 ps) also exhibit the trans -+ cis isomer-
ization of the Gla-21--Pro-22 peptide bond (81-83 ps); how-
ever, preliminary results suggest significant structural differ-
ences from the average Ca-BF1 structure consistent with the
inability of magnesium to mediate phospholipid binding (1-
6). For example, the difference between backbone deviations
for the average final 20-ps Ca-BF1 and Mg-BF1 structures is
3.9A.
Although our initial assignment of calcium positions was
largely qualitative, the coordination analysis is suggestive.
Our results support current hypotheses (7, 23), which expand
the functional definition of the Gla domain to include residues
1-65. We further conclude that one tight-binding calcium site
lies between Gla residues 7 and 26, whereas another consists
of an unusual two-metal, two-Gla site between Gla residues
20 and 21.
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